Global initiative addressing personalised and preventative health to be launched during the eventABU DHABI, UAE, April 10, 2025 /PRNewswire/ -- With rising global demand for more personalised ...

With rising global demand for more personalised and effective healthcare solutions, the Department of Health - Abu Dhabi (DoH ...

Trump said overnight that the US would soon introduce a 'major tariff' on pharmaceuticals to force firms to relocate medicine ...

Ohio and Indiana are suing the makers of a popular heartburn medication, saying the drug company concealed cancer risks and ...

Shares of Britain's two leading pharmaceutical companies, AstraZeneca and GSK, fell sharply on Wednesday following fresh ...

Ministers must treat medicines supplies as a ‘defence’ issue as it faces ‘hostile activity’ over the brewing trade war ...

Programs will leverage ABL Bio's Grabody-B platform technology to deliver molecules across the blood-brain barrier.

ABL Bio Inc. sealed a potential £2.075 billion (US$2.65 billion) license deal with GSK plc, granting GSK global rights to use ABL’s blood-brain barrier penetrating bispecific antibody platform, ...

Pharma firm GSK has been accused of burying a report said to prove a link between its medication Zantac and cancer, a new ...